Quantitative CD3 PET Imaging Predicts Tumor Growth Response to Anti-CTLA-4 Therapy. - Wikidata - awgldk - TriplyDB

Quantitative CD3 PET Imaging Predicts Tumor Growth Response to Anti-CTLA-4 Therapy.

Quantitative CD3 PET Imaging Predicts Tumor Growth Response to Anti-CTLA-4 Therapy.

http://www.wikidata.org/entity/Q37722443

about

Molecular Imaging of Immunotherapy Targets in Cancer.ImmunoPET Imaging of CTLA-4 Expression in Mouse Models of Non-small Cell Lung Cancer.In Vivo PET Imaging of the Activated Immune Environment in a Small Animal Model of Inflammatory Arthritis Evaluation of response to immune checkpoint inhibitors: Is there a role for positron emission tomography?T cell densities in brain metastases are associated with patient survival times and diffusion tensor MRI changes.Tumor-associated macrophages, nanomedicine and imaging: the axis of success in the future of cancer immunotherapy.Clinical characteristics of patient selection and imaging predictors of outcome in solid tumors treated with checkpoint-inhibitors.Immuno-PET imaging of tumor-infiltrating lymphocytes using zirconium-89 radiolabeled anti-CD3 antibody in immune-competent mice bearing syngeneic tumors.Granzyme B PET Imaging as a Predictive Biomarker of Immunotherapy Response.Role of noninvasive molecular imaging in determining response

P2860

Q37309882-0293F9C9-47C0-4432-841B-B231CD02DE0C Q38733611-C68A9AE3-8572-4F79-AC6F-0BDD7C06CA0E Q41068428-9F829720-D0A6-4BD2-9292-7EA4AA5DA569 Q42318752-290AFD14-B26B-457C-A944-BAEFECEB9E51 Q47322246-498F6932-966C-4046-8B7D-6EFD31559996 Q47962563-A4BBAC8B-21B7-4C32-A9B4-2902EC9604F1 Q48227716-CEA0A8B9-0731-43A2-B7FA-7CE898C7E4F4 Q50532150-B4AAD128-4ACB-4A8A-8879-38EC9ADFBA34 Q52874301-171FC5A1-8FB7-4430-9CB1-7A9BFB61FD73 Q58119177-CCADBE89-5045-4AAB-ACDC-5AD1BC1503C9

P2860

Quantitative CD3 PET Imaging Predicts Tumor Growth Response to Anti-CTLA-4 Therapy.

http://www.wikidata.org/entity/Q37722443

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 26 May 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Quantitative CD3 PET Imaging Predicts Tumor Growth Response to Anti-CTLA-4 Therapy.

@en

Quantitative CD3 PET Imaging Predicts Tumor Growth Response to Anti-CTLA-4 Therapy.

@nl

type

label

Quantitative CD3 PET Imaging Predicts Tumor Growth Response to Anti-CTLA-4 Therapy.

@en

Quantitative CD3 PET Imaging Predicts Tumor Growth Response to Anti-CTLA-4 Therapy.

@nl

prefLabel

Quantitative CD3 PET Imaging Predicts Tumor Growth Response to Anti-CTLA-4 Therapy.

@en

Quantitative CD3 PET Imaging Predicts Tumor Growth Response to Anti-CTLA-4 Therapy.

@nl

P1433

Q37722443-BD627751-C02A-4A0B-8B9A-12179175B871

P1476

Q37722443-515B269A-68B4-4F70-AC2C-1E5F6AC7BBF4

P2093

Q37722443-25C0C97A-DC3A-4A48-B04D-88826C8F6B51

Q37722443-57F003C9-DAF5-407A-8F5B-5B9AEEEC3545

Q37722443-84B63432-6D72-4925-BD69-F49E30BA3010

Q37722443-8E286E29-8C16-476C-8E14-6340A0CDA806

P2860

Q37722443-04E358A1-5E51-40AA-8465-FF044B8F005A

Q37722443-09131DCE-2B85-4068-B5C5-380D67EB6E44

Q37722443-1F75DC23-5D38-4482-BEAB-1AEC0AAC813F

Q37722443-3FD4EF97-585D-4EA4-9677-E17C1623CDA5

Q37722443-406F5A37-6573-4CF6-A26D-307A58279796

Q37722443-4C23A4D8-291A-45A8-896C-7093A76378AA

Q37722443-6CA1FE5B-ADCE-42BC-B5B9-1E2EED1DBC21

Q37722443-6DF17555-E222-430D-AC29-4BC9901D7F8B

Q37722443-7DE468F6-4B46-4BC5-9A89-C7C1A59A88BA

Q37722443-92FDE272-6242-406E-83CB-9CD70159C05B

P304

Q37722443-FD420C21-E52D-4B73-B4D8-8A2B9B91CBC0

P31

Q37722443-3C02F2C2-4F62-4B0C-802F-B3FFD56C9281

P356

Q37722443-30CEA5D6-272B-44A6-B9A8-3782D16E7877

P407

Q37722443-D3537149-0E61-4C5C-90A7-33969D77AFB1

P433

Q37722443-0606D7E5-B546-420A-BF95-4B81847B35B8

P478

Q37722443-BB98F280-A18C-454E-8EA6-6759E9535B19

P577

Q37722443-7DC818CA-DCE0-47C7-A4EF-38D2CC5B585F

P698

Q37722443-CD35BBFA-46F8-4A7E-9537-40761DF2DA16

P932

Q37722443-3A4AC947-03E3-4DC6-99B2-A7ED953A727F

P356

JNUMED.116.173930

P1433

The Journal of Nuclear Medicine

P1476

Quantitative CD3 PET Imaging Predicts Tumor Growth Response to Anti-CTLA-4 Therapy.

@en

P2093

Alexander Caraballo

http://www.w3.org/2001/XMLSchema#string

Benjamin M Larimer

http://www.w3.org/2001/XMLSchema#string

Eric Wehrenberg-Klee

http://www.w3.org/2001/XMLSchema#string

Umar Mahmood

http://www.w3.org/2001/XMLSchema#string

P2860

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer

Nivolumab and ipilimumab versus ipilimumab in untreated melanoma

Pembrolizumab for the treatment of non-small-cell lung cancer

PD-1 blockade induces responses by inhibiting adaptive immune resistance

Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer

Engineering high-affinity PD-1 variants for optimized immunotherapy and immuno-PET imaging

P304

1607-1611

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2967/JNUMED.116.173930

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

57

http://www.w3.org/2001/XMLSchema#string

P577

2016-05-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27230929

http://www.w3.org/2001/XMLSchema#string

P932

5367446

http://www.w3.org/2001/XMLSchema#string